139 results
Page 2 of 7
8-K
EX-99.1
k75nwaffv2mhit
12 May 23
Adaptimmune Reports First Quarter Financial Results and Business Update
7:36am
424B3
f0w 37vlrx5kwluc2
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
d57nwt2rit9aupy7jii6
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
8-K
EX-10.1
3sq1zii8ek bv
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
EX-2.2
f4o 58mfdwac1yq
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
S-4
2gcu g56vhx
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
l8qzdhf94k
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
kg4 q5tov9
28 Apr 22
Prospectus supplement for primary offering
8:09am